The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Ishares Nasdaq Biotechnology

Nasdaq: IBB
Last

(U.S.) $303.87

Today's change+4.20 +1.40%
Updated November 26 4:00 PM -5GMT. Delayed by at least 15 minutes.
 

Ishares Nasdaq Biotechnology

Nasdaq: IBB
Last

(U.S.) $303.87

Today's change+4.20 +1.40%
Updated November 26 4:00 PM -5GMT. Delayed by at least 15 minutes.

Ishares Nasdaq Biotechnology Hits New 52-week High

Ishares Nasdaq Biotechnology closed up Wednesday by (U.S.)$4.20 or 1.40% to (U.S.)$303.87 and setting a new 52-week high. Over the last five days, shares have gained 3.28% and 33.83% year to date. Shares have outperformed the S&P 500 by 21.01% during the last year.

Key company metrics

  • Open(U.S.) $299.88
  • Previous close(U.S.) $299.67
  • High(U.S.) $303.87
  • Low(U.S.) $299.40
  • Bid / Ask-- / --
  • YTD % change+33.83%
  • Volume824,799
  • Average volume (10-day)1,210,239
  • Average volume (1-month)1,301,853
  • Average volume (3-month)1,357,150
  • 52-week range(U.S.) $207.48 to (U.S.) $303.87
  • Beta0.92
  • Trailing P/E4.70×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.45
  • Dividend yield0.15%
  • Trailing EPS(U.S.) $64.65
Updated November 26 4:00 PM -5GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q2/2014Q4/2013Q2/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201403/31/2014Sep 30, 201309/30/2013Mar 31, 201303/31/2013Sep 30, 201209/30/2012
Revenue98510
Total other revenue--------
Total revenue98510
Gross profit--------
Total cost of revenue--------
Total operating expense11855
Selling / general / administrative11855
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-20-16
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax446878259291
Income after tax446878259291
Income tax, total0000
Net income446878259291
Total adjustments to net income--------
Net income before extra. items446878259291
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items446878259291
Inc. avail. to common incl. extra. items446878259291
Diluted net income446878259291
Dilution adjustment0------
Diluted weighted average shares23191517
Diluted EPS excluding extraordinary itemsvalue per share19.0345.6216.7617.18
Dividends per sharevalue per share0.000.070.100.53
Diluted normalized EPSvalue per share19.0345.6216.7617.18